RapiPRO™ LAMP SARS-CoV-2 works seamlessly with RapiPREP® technology, amplifying extracted RNA from a patient’s nasal swab sample to confirm the presence of SARS-CoV-2 in less than 30 minutes.
RapiPRO™ LAMP SARS-CoV-2 can also be used with other commercially available nucleic acid extraction kits. The test is in the final stages of clinical validation.
RapiPRO™ LAMP SARS-CoV-2 amplification can provide accurate results from samples which vary in size and quality, including those which have suffered biological degradation.
The amplification is carried out isothermally and can be performed with a range of basic cost-effective equipment; both in a high throughput facility – including those currently configured for PCR testing – or in a close to patient setting by a technician with minimal training.
It works efficiently on several platforms, including Genie® II, Genie® III and Genie ® HT – with the latter for use in high-throughput environments, and each enabling up to eight, 16 or 96 samples to be analysed at one time.
To get in touch with one of our team, call +44 (0)20 76912147 or email firstname.lastname@example.org
The most accurate and sensitive SARS-CoV-2 tests, Loop-mediated Isothermal Amplification (LAMP) and, polymerase chain reaction (PCR), both require RNA to be extracted from a patient’s sample before it can be amplified and analysed.
The Seprion™ range of products detect aggregated proteins associated with Parkinson’s, Alzheimers, Huntington’s disease, and the Transmissible Spongiform Encephalopathies such as BSE, scrapie, vCJD and CWD.